Skip to main content

Table 3 Postoperative outcomes

From: Fluid management in patients undergoing cardiac surgery: effects of an acetate- versus lactate-buffered balanced infusion solution on hemodynamic stability (HEMACETAT)

CharacteristicsRinger’s acetate (n = 75)Ringer’s lactate (n = 73)p value*
Occurrence of arrhythmia, n (%)24 (32.0)39 (53.4)0.008
Acute kidney injury, n (%)#11 (14.7)10 (13.7)0.866
 Risk1080.901
 Injury11 
 Failure01 
New neurological deficit, med (IQR)4 (5.3)7 (9.6)0.324
 Critical illness polyneuropathy01 
 Ischemic stroke45 
 Peripheral nerve lesion01 
Coronary angiography, n (%)2 (2.7)5 (6.9)0.272
Postoperative drainage output950 (550–1200)1000 (560–1320)0.415
Received blood product transfusion, n (%)24 (32.0)19 (26.0)0.424
Postoperative infection, n (%)4 (5.3)3 (4.1)1.000
Other complications, n (%)8 (10.7)4 (5.5)0.368
 Delirium10 
 Pneumothorax20 
 Significant pleural effusion21 
 Skin rash11 
 Transient hypoxemia22 
Surgical re-exploration needed, n (%)2 (2.7)6 (8.2)0.166
Need for postoperative mechanical circulatory support, n (%)0(0.0)2 (2.7)+0.242
Length of stay [days], med (IQR)
 ICU0.9 (0.7–0.9)0.9 (0.8–0.9)0.494
 IMC0.0 (0.0–0.0)0.0 (0.0–1.0)0.362
 Hospital9.0 (8.0–12.0)9.0 (8.0–10.2)0.425
In-hospital mortality00 
  1. #According to the RIFLE criteria
  2. *Wilcoxon rank sum test for continuous and Fisher’s exact test for categorical variables between the Ringer’s acetate and Ringer’s lactate study groups
  3. +One patient arrived with IABP from the OR, and one patient needed veno-arterial ECMO support in ICU